Mediators of Inflammation / 2020 / Article / Tab 4

Research Article

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 4

Serum levels of immunoglobulins and complements in patients with and without type 2 diabetes.

VariablesNormal rangeNDM ()T2D () value
MedianIncreased no. (%)Decreased no. (%)MedianIncreased no. (%)Decreased no. (%)

IgG (g/L)7-1623.832 (6.5%)1 (3.2%)25.210 (27.8%)1 (2.8%)0.547
IgM (g/L)0.4-2.31.030 (0.0%)1 (3.2%)1.022 (5.6%)0 (0.0%)0.680
IgA (g/L)0.7-4.02.872 (6.5%)0 (0.0%)3.138 (22.2%)1 (2.8%)0.457
IgE (IU/mL)<10088.55 (16.1%)0 (0.0%)163.413 (36.1%)0 (0.0%)
C3 (g/L)0.9-1.81.030 (0.0%)3 (9.7%)1.011 (2.8%)7 (19.4%)0.402
C4 (g/L)0.1-0.40.234 (12.9%)1 (3.2%)0.253 (8.3%)1 (2.8%)0.839

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.